| |
GENETIC TECHNOLOGIES LIMITED Company Summary |
|
| Genetic Technologies was an early pioneer in recognizing important new applications for "non-coding" DNA (DeoxyriboNucleic Acid). The Company has since been granted patents in 24 countries around the world, securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species. Its three-pronged business strategy includes: 1) the global commercialization of its patents through an active licensing program; 2) the expansion of its dominant commercial genetic testing business in Australia; and, 3) the commercialization of its various research and development projects aimed at generating further intellectual property of global commercial significance. |
|
|
|
 |
Fax |
(03) 9417 2987 |
 |
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
1987/07/30 |
|
|
Homepage |
www.gtg.com.au/ |
|
| |
|
|
|
|
| |
NEWS |
 |
|
|  Genetic Technologies (ASX: GTG) Advise on Progress with Intellectual Property Licensing on Non-coding DNA (JAN 15, 2008) | | Aust Market Wrap, (ASX: MMX), (ASX: MBL), (ASX: PBL), (ASX: CPB), (ASX: RXM), (ASX: PNA), (ASX: CTX), (ASX: GTG) (SEP 20, 2007) | | Aegis Equities Research Announce Health and Life Science Review, August 2006 (AUG 15, 2006) | | Genetic Technologies Expands Paternity Testing Services into China (JUNE 16, 2006) |
|
|
|
|
